We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Baker McKenzie (Gaikokuho Joint Enterprise) offers deep bench strength in Tokyo when it comes to M&A work, with its sizeable team operating in relation to cross-border matters in the semiconductor, TMT, finance, real estate, and healthcare sectors, among others. Practice head Jiro Toyokawa has broad experience in public and private M&A, with large-scale outbound M&A transactions involving Japanese financial institutions an area of strength. Akifusa Takada, co-managing partner of the firm’s Tokyo office, advises on a wide range of domestic transactions, including M&A, group reorganisations, joint ventures, and private equity transactions. His client portfolio includes companies in the financial services, pharma, industrial, food, and service sectors. Kiyoshi Endo’s practice covers inbound and outbound M&A. Tetsuo Tsujimoto and Yutaka Kimura are also key players in the team.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘We have received legal support from Tetsuo Tujimoto and his team on various matters such as joint venture investments, group reorganisations, and other M&A matters, etc. His team provides us with optimal solutions based on his extensive experience and broad knowledge.'
‘In addition to Jiro Toyokawa's professional legal skills and experience, he always understands the issues we have and clearly explains what is important for us now and advises us what kind of risks we have and our options in every situation.'
Key clients
- Mitsubishi Electric Corporation
- Sumitomo Life Insurance Company
Work highlights
Advised Mitsubishi Electric Corporation (MELCO) on its investment in Coherent Corp.'s silicon carbide semiconductor business amounting to $500m.
Acted for Sumitomo Life Insurance Company in its acquisition of 25.94% stake in Singapore Life Holdings Pte. Ltd. (Singlife), together with two debt instruments including reset subordinated perpetual capital securities issued by Singlife, held by Aviva Group Holdings Limited for a combined consideration of around SGD 1.4bn.